IASLC WCLC 2018

Q: 如果IASLC WCLC 2018在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載IASLC WCLC 2018。

Q: 運行IASLC WCLC 2018的最低配置要求是什麼？

以下為IASLC WCLC 2018的最低配置要求。<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

Free

5.0.0for iPhone, iPad

Webges Meeting Applications

Developer

2018年09月14日

Update Date

Education

Category

APKPure

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

IASLC WCLC 2018 螢幕截圖

iPad

iPhone

About IASLC WCLC 2018

The IASLC 19th World Conference on Lung Cancer (WCLC 2018) is the premier international gathering of physicians and researchers in the field of lung cancer and thoracic malignancies. The Conference motto “Take Action Against Lung Cancer” captures the collaborative spirit of the Conference which will be both a scientific and educational event.

Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients will come together in order to obtain and exchange information on advances in the management of lung cancer and other thoracic malignancies, while considering both global and regional aspects.